Variant position: 473 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1257 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human APVPSVQWLDEDGTTVLQDE RFFPYANGTLGIRDLQANDTG
Mouse APVPSVQWLDEEGTTVLQDE RFFPYANGTLSIRDLQANDTG
Rat APVPSVQWLDEEGTTVLQDE RFFPYANGHLGIRDLQANDTG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
20 – 1257 Neural cell adhesion molecule L1
20 – 1120 Extracellular
425 – 507 Ig-like C2-type 5
479 – 479 N-linked (GlcNAc...) asparagine
490 – 490 N-linked (GlcNAc...) asparagine
448 – 497
Identification of novel L1CAM mutations using fluorescence-assisted mismatch analysis.
Saugier-Veber P.; Martin C.; le Meur N.; Lyonnet S.; Munnich A.; David A.; Henocq A.; Heron D.; Jonveaux P.; Odent S.; Manouvrier S.; Moncla A.; Morichon N.; Philip N.; Satge D.; Tosi M.; Frebourg T.;
Hum. Mutat. 12:259-266(1998)
Cited for: VARIANTS HSAS/MASA ARG-335 AND CYS-473; VARIANTS HSAS THR-219; CYS-386 AND LEU-1224;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.